SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Deferred Tax Assets, Valuation Allowance

SCINAI IMMUNOTHERAPEUTICS LTD. Deferred Tax Assets, Valuation Allowance

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Deferred Tax Assets, Valuation Allowance of $28.52 million as of 2025-12-31, per its 20-F filed 2026-04-01.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-04-01

• 2025-12-31: Deferred Tax Assets, Valuation Allowance $28.52M.
• 2024-12-31: Deferred Tax Assets, Valuation Allowance $23.70M.
• 2023-12-31: Deferred Tax Assets, Valuation Allowance $26.42M.
• 2022-12-31: Deferred Tax Assets, Valuation Allowance $22.36M.